-
Entity
-
Individual
-
Location
-
C/O Cascadian Therapeutics, Inc., 3101 Western Ave., Suite 600, Seattle, Washington
-
Summary
-
The estimated net worth of Scott Dunseth Myers is at least $5.8 M dollars as of May 28, 2024. Scott Dunseth Myers is the Chief Executive Officer, Director of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $5.45 M. Scott Dunseth Myers is the Director of DYNAVAX TECHNOLOGIES CORP and owns shares of DYNAVAX TECHNOLOGIES CORP (DVAX) stock worth about $290 K. Scott Dunseth Myers is the Director of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. (HARP) stock worth about $64.4 K.